This document discusses the increasing regulatory requirements and risks around flexible food packaging. It notes that brand owners are demanding more testing and transparency from suppliers to ensure packaging safety. Material suppliers must understand how their products will be used and potential hazards to determine if they are suitable. The document also summarizes key regulations for food packaging in the US and EU and discusses approaches for determining if a product is suitable for a given use in the absence of specific regulations, including understanding the product formulation, end use conditions, potential migration, and risk assessment.
Emma Bradley from Fera Science Ltd presented on food contact materials and migration testing. Key points included:
- Migration occurs when chemicals transfer from food packaging into food and is influenced by factors like the material, substance, food, and contact conditions.
- EU legislation establishes rules for materials, substances, testing, and compliance documentation like declarations of compliance.
- Specific rules apply to plastics, which must use authorized monomers/additives and meet migration limits through testing with food simulants intended to mimic food types.
This document provides an overview of safety evaluation and standards for food packaging materials in China. It discusses the inspection and evaluation requirements for food packaging materials, including required chemistry and toxicology information. It also outlines the major regulations on packaging materials in China's Food Safety Law. Finally, it describes China's food packaging material safety standard system, including horizontal standards, additive lists, material standards, and test methods.
This document discusses risk assessment of food packaging and contact materials. It provides an overview of topics including the reasons for packaging, packaging migration factors, common packaging materials and types, regulatory approaches for food contact substances in various regions including the US, EU, Japan and others. It also outlines the types of data typically required by regulators for approval of new food contact substances, including chemistry information, migration testing conditions and protocols, and toxicology data recommendations based on expected exposure levels.
This presentation discusses contamination of food from packaging materials. It notes that chemicals in plastic grocery bags and PVC plasticizers can leach into food and cause health issues. The document also analyzes microbial contamination of paper-based packaging, finding higher contamination with higher recycled fiber content. Finally, it discusses how different packaging materials like plastic bottles, glass jars, cartons and cans can contact food, and the importance of understanding chemical migration from packaging into food.
This document discusses issues with plastic food packaging, specifically the migration of monomers from plastic packaging into food. It notes that while plastic packaging has benefits like extending shelf life and being low cost, it can also leach unreacted monomers and breakdown products into food. Some monomers have been proven carcinogenic or toxic. It then lists some common monomers from plastic packaging and explains the three stages of monomer migration from the plastic into food through diffusion, solvation at the interface, and dispersion into the bulk food. Finally, it provides some regulations from the EU and US to limit food contamination from monomers.
Driving Profitable Growth Despite All the Landmines in the Food & Beverage In...StantonAssociates
Webinar presented by the Food & Beverage Industry Alliance
- How to navigate the complex regulatory environment
- How to stand out in today's crowded marketplace
- How to use Business Intelligence Systems to make superior decisions to drive growth and profitability
-
This document discusses compliance packaging standards for pharmaceutical products. It identifies three levels of packaging: primary, secondary, and tertiary. It then lists 14 compliance standards that packaging must meet, such as including descriptions of drug appearance, placement of labels, lot numbers and expiration dates. Compliance packaging helps ensure proper patient dosing, supports treatment effectiveness, and simplifies packaging requirements while maximizing drug utilization and minimizing waste. It also discusses disposal of packaging and certifications to ensure the packaging meets all legal and safety obligations.
A recall is one of every brand's biggest concerns. At Sensient, we test and certify every solution so that you can be sure your products will be safe on shelves.
Emma Bradley from Fera Science Ltd presented on food contact materials and migration testing. Key points included:
- Migration occurs when chemicals transfer from food packaging into food and is influenced by factors like the material, substance, food, and contact conditions.
- EU legislation establishes rules for materials, substances, testing, and compliance documentation like declarations of compliance.
- Specific rules apply to plastics, which must use authorized monomers/additives and meet migration limits through testing with food simulants intended to mimic food types.
This document provides an overview of safety evaluation and standards for food packaging materials in China. It discusses the inspection and evaluation requirements for food packaging materials, including required chemistry and toxicology information. It also outlines the major regulations on packaging materials in China's Food Safety Law. Finally, it describes China's food packaging material safety standard system, including horizontal standards, additive lists, material standards, and test methods.
This document discusses risk assessment of food packaging and contact materials. It provides an overview of topics including the reasons for packaging, packaging migration factors, common packaging materials and types, regulatory approaches for food contact substances in various regions including the US, EU, Japan and others. It also outlines the types of data typically required by regulators for approval of new food contact substances, including chemistry information, migration testing conditions and protocols, and toxicology data recommendations based on expected exposure levels.
This presentation discusses contamination of food from packaging materials. It notes that chemicals in plastic grocery bags and PVC plasticizers can leach into food and cause health issues. The document also analyzes microbial contamination of paper-based packaging, finding higher contamination with higher recycled fiber content. Finally, it discusses how different packaging materials like plastic bottles, glass jars, cartons and cans can contact food, and the importance of understanding chemical migration from packaging into food.
This document discusses issues with plastic food packaging, specifically the migration of monomers from plastic packaging into food. It notes that while plastic packaging has benefits like extending shelf life and being low cost, it can also leach unreacted monomers and breakdown products into food. Some monomers have been proven carcinogenic or toxic. It then lists some common monomers from plastic packaging and explains the three stages of monomer migration from the plastic into food through diffusion, solvation at the interface, and dispersion into the bulk food. Finally, it provides some regulations from the EU and US to limit food contamination from monomers.
Driving Profitable Growth Despite All the Landmines in the Food & Beverage In...StantonAssociates
Webinar presented by the Food & Beverage Industry Alliance
- How to navigate the complex regulatory environment
- How to stand out in today's crowded marketplace
- How to use Business Intelligence Systems to make superior decisions to drive growth and profitability
-
This document discusses compliance packaging standards for pharmaceutical products. It identifies three levels of packaging: primary, secondary, and tertiary. It then lists 14 compliance standards that packaging must meet, such as including descriptions of drug appearance, placement of labels, lot numbers and expiration dates. Compliance packaging helps ensure proper patient dosing, supports treatment effectiveness, and simplifies packaging requirements while maximizing drug utilization and minimizing waste. It also discusses disposal of packaging and certifications to ensure the packaging meets all legal and safety obligations.
A recall is one of every brand's biggest concerns. At Sensient, we test and certify every solution so that you can be sure your products will be safe on shelves.
The document summarizes the transition from Material Safety Data Sheets (MSDS) to Safety Data Sheets (SDS) as mandated by the Globally Harmonized System of Classification and Labeling of Chemicals (GHS). Key points include:
- MSDS will be replaced by SDS, which have a standardized 16-section format.
- New labeling requirements include standardized pictograms and a revised hazard classification system.
- For pesticide products, both the MSDS and SDS may need to be maintained to comply with GHS and EPA regulations.
- Employers have until June 2016 to be fully compliant with the new GHS standards.
“Evolution of biosimilar medicines assessment in Russia. Current practices and main challenges”
Illustrates the current Russian legislative scenario and ongoing developments on the regulation of biotherapeutics and biosimilars
This document discusses complex generics and the challenges involved in developing them. It defines complex generics as medicines that are substitutes for specialized originator products and must demonstrate bioequivalence, but require proving additional "sameness" parameters during development. Developing complex generics faces formulation challenges, intellectual property barriers, clinical trial design issues, and establishing equivalence. They are more difficult to manufacture than simple generics due to the need for precise control over critical parameters like particle size.
The document discusses the need for quality assurance tools for the detection and measurement of nanomaterials in food and consumer products. It notes that millions of measurements are performed each year and important decisions are based on these measurements. However, there is a need for harmonization and standardization of measurement methods. The document outlines some of the challenges around developing reference materials and analytical methods for detecting nanomaterials in complex matrices. It presents some of the work done by the EC-JRC to address these challenges, such as developing validated methods and producing certified reference materials to improve measurement quality and comparability.
- Dr Hnin Nandar Kyaw outlined the organization and laws related to food labeling in Myanmar. The Food and Drug Administration (FDA) regulates food safety and labeling through various divisions. The main laws are the 1997 National Food Law and the 2014 Directive Order on formulated foods for infants and young children.
- Currently, FDA refers to Codex Alimentarius standards for guidance on labeling. A new food law is being drafted to modernize regulations. A directive order on comprehensive food labeling, including nutrition labeling, will be based on Codex guidelines.
- The infant formula order has detailed labeling requirements covering appearance, prohibited claims, languages, and mandatory nutrition information. FDA aims to strengthen food safety measures in line
The document discusses reducing transaction costs associated with trade through facilitating compliance with sanitary and phytosanitary (SPS) requirements. It outlines how SPS measures can increase transaction costs for producers and consumers if they are not standardized or scientifically justified. The document recommends ways for countries and firms to analyze SPS requirements, comply with trading partners' regulations to minimize trade losses, and pursue long-term solutions like international standards and agreements.
Chapter 6; eco labelling (oeko tex-100 and eu eco-label)Shaheen Sardar
The document summarizes information about two eco-labeling schemes - Oeko-Tex and the EU Ecolabel. Oeko-Tex is a voluntary certification system that tests textiles for harmful substances. It has four product classes based on a product's contact with skin. The EU Ecolabel aims to encourage environmentally friendly products and has criteria covering the entire life cycle from extraction to disposal. Both labels provide advantages to textile producers including health and environmental protections.
This document summarizes the global regulatory landscape for biosimilars. It begins by defining biosimilars and biological drugs. It then discusses the guidelines established by various regulatory bodies including the EMA, FDA, WHO, and agencies in countries like Japan, Korea, Canada, China, and India. The guidelines generally require demonstrating biosimilarity to the reference product through comparative quality, nonclinical and clinical studies. The document also discusses business opportunities for biosimilars in emerging versus established markets and strategies used by originator companies to combat biosimilar competition. It concludes by noting concerns around interchangeability between biosimilars and reference products.
This document discusses biologics and biosimilars. It defines biologics as biological products made from natural sources like humans, animals or microorganisms that are used to treat or prevent diseases. Biosimilars are highly similar versions of biologics that are approved because they have no clinically meaningful differences. The document outlines key differences between biologics and biosimilars like regulatory pathways and development testing. It also compares biosimilars to generics and discusses important considerations for biosimilar development like immunogenicity, bioequivalence and post-translational modification.
FDA 2013 Clinical Investigator Training Course: Biosimilar Biological ProductsMedicReS
This document provides an overview of biosimilar biological products from a presentation given by Dr. Sue Lim of the FDA. It defines biological products and biosimilars. Biosimilars are developed using a stepwise approach to demonstrate biosimilarity to a reference product through analytical, nonclinical and clinical studies. Clinical study design considerations for biosimilars include using endpoints sensitive to potential differences, assessing products at time points most likely to detect differences, using the same or similar patient populations and doses as the reference product, and evaluating safety including immunogenicity over a duration adequate to detect potential impacts.
Determinations for lead and the eight elements in ASTM F963 as a means for third party testing cost reduction: questions, issues, and comments. CPSC staff presentation followed by panelist presentations
This document discusses biosimilars and their regulation. It begins with a brief history of biotechnology and biopharmaceuticals. It then defines biosimilars as similar but not generic versions of biologic drugs whose patents have expired. The document outlines key differences between biosimilars and generic drugs, including their larger and more complex molecular structures. It also discusses concerns regarding biosimilar efficacy, safety, interchangeability, and pharmacovigilance. Finally, it provides an overview of regulatory frameworks for biosimilars in various regions like the EU, US, India, and WHO guidelines.
This working paper discusses preliminary results from a survey of 15 biopharmaceutical manufacturing sites regarding regulatory economics. The survey collected data on site characteristics, quality approaches, and perceptions of regulatory inspections. Logistic regression found some factors like prior production elsewhere or use of mammalian cell culture were statistically related to reported quality deviations. The full project aims to incorporate FDA inspection data and understand how globalization impacts regulatory compliance in biopharmaceutical manufacturing to help inform FDA policy.
Instrument or Experimental Technique Used In Food Chemical Composition Analysisholem
This document discusses four main analytical instrument techniques used in food chemical composition analysis: gas chromatography (GC), high performance liquid chromatography (HPLC), differential scanning calorimeter (DSC), and ultraviolet-visible spectrophotometer. It provides an overview of each technique, including their aims and uses in food analysis. GC is used to separate and analyze compounds that can be vaporized, HPLC separates mixtures using liquid mobile and stationary phases, DSC measures heat flows during material transitions, and UV-VIS spectrophotometry determines substance identities and concentrations by measuring light absorption.
This document provides an overview of eco-labels in textiles. It discusses the history and rise of eco-labels in the 1970s-1980s to address consumer confusion over environmental claims. It describes different types of eco-labeling schemes including independent labels, national labels, and multinational labels. It then examines specific eco-label programs like the Blue Angel (Germany), EU Eco-label, and Nordic Eco-labeling scheme, outlining their objectives, product categories, features, and chemical restrictions.
February 7, 2017
Many of today’s important medications are biological products made from living organisms, manufactured through biotechnology, derived from natural sources, or produced synthetically. Biosimilars are a type of biological product approved by FDA on the basis of being highly similar to an already approved biological reference product.
This panel of experts discussed the current state of biosimilars in the healthcare ecosystem and what comes next from a technical and legal perspective. Topics included how the next generation of biosimilars could improve patient access to standard-of-care therapies, the concept of “biobetters,” economic and intellectual property considerations, and policy approaches to support existing and future biosimilars.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/looking-forward
Phthalate determinations as a means for third party testing cost reduction: questions, issues, and comments. CPSC staff presentation followed by panelist presentations.
With 35+ years of experience across the food science and packaging spectrum, Dr Claire Sand, owner and founder of Packaging Technology & Research, helps clients achieve
more sustainable packaging,
increase shelf life/prevent food waste,
leverage food packaging innovations,
address food package optimization
and serves the food and packaging industry as
a food packaging expert witness
adjunct professor
columnist for Food Technology and Packaging Digest
Want to know more about how this article affects your business? Reach out to Dr. Sand on LinkedIn - https://www.linkedin.com/in/clairekoelschsand
Want to keep learning from Dr. Sand? View more of her presentations and articles at https://www.packagingtechnologyandresearch.com/insights.html
Dr. Claire Sand | Owner, Packaging Technology & Research, LLC; Adjunct Professor, CalPoly and Michigan State University; Columnist for Food Technology Magazine and Packaging Digest http://www.packagingtechnologyandresearch.com/
The document discusses the importance of packaging for pharmaceutical products. It outlines several key functions of packaging including uniformity, purity, integrity, minimizing side effects, and ensuring stability and a defined shelf life. It also classifies different types of packaging materials like primary, secondary and tertiary packaging. Specific materials that are used include glass, plastics, polyethylene, polypropylene, and others. The role of packaging technology in preventing counterfeiting is also covered through various techniques like ink technology, RFID tags, tamper-evident stickers, and holograms. Packaging can also help promote patient compliance and provide informative labeling.
This document provides an overview of maximizing and extending shelf-life for food and beverage products. It discusses best before and use by dates, the steps for setting shelf-life which include establishing product parameters, checking legislation, identifying microorganisms of concern, conducting shelf-life testing, and ongoing review. Extending shelf-life can offer benefits but safety and quality must not be compromised. Considerable expertise is needed to properly set or extend shelf-life to ensure legal compliance and protection of consumers.
The document discusses pharmaceutical packaging technology. It covers the functions of packaging which include barrier protection, biological protection, physical protection, information communication, identification, security and convenience. It also discusses the different types of pharmaceutical packaging including primary, secondary and tertiary packaging. Primary packaging materials can include glass, plastic, metal while secondary packaging uses materials like boxes, cartons and shrink wraps. The selection of packaging depends on the dosage form and its requirements to provide stability and prevent chemical reactions or degradation from light, heat and moisture. Packaging ensures safe delivery of drugs to patients and provides important labeling information.
The document summarizes the transition from Material Safety Data Sheets (MSDS) to Safety Data Sheets (SDS) as mandated by the Globally Harmonized System of Classification and Labeling of Chemicals (GHS). Key points include:
- MSDS will be replaced by SDS, which have a standardized 16-section format.
- New labeling requirements include standardized pictograms and a revised hazard classification system.
- For pesticide products, both the MSDS and SDS may need to be maintained to comply with GHS and EPA regulations.
- Employers have until June 2016 to be fully compliant with the new GHS standards.
“Evolution of biosimilar medicines assessment in Russia. Current practices and main challenges”
Illustrates the current Russian legislative scenario and ongoing developments on the regulation of biotherapeutics and biosimilars
This document discusses complex generics and the challenges involved in developing them. It defines complex generics as medicines that are substitutes for specialized originator products and must demonstrate bioequivalence, but require proving additional "sameness" parameters during development. Developing complex generics faces formulation challenges, intellectual property barriers, clinical trial design issues, and establishing equivalence. They are more difficult to manufacture than simple generics due to the need for precise control over critical parameters like particle size.
The document discusses the need for quality assurance tools for the detection and measurement of nanomaterials in food and consumer products. It notes that millions of measurements are performed each year and important decisions are based on these measurements. However, there is a need for harmonization and standardization of measurement methods. The document outlines some of the challenges around developing reference materials and analytical methods for detecting nanomaterials in complex matrices. It presents some of the work done by the EC-JRC to address these challenges, such as developing validated methods and producing certified reference materials to improve measurement quality and comparability.
- Dr Hnin Nandar Kyaw outlined the organization and laws related to food labeling in Myanmar. The Food and Drug Administration (FDA) regulates food safety and labeling through various divisions. The main laws are the 1997 National Food Law and the 2014 Directive Order on formulated foods for infants and young children.
- Currently, FDA refers to Codex Alimentarius standards for guidance on labeling. A new food law is being drafted to modernize regulations. A directive order on comprehensive food labeling, including nutrition labeling, will be based on Codex guidelines.
- The infant formula order has detailed labeling requirements covering appearance, prohibited claims, languages, and mandatory nutrition information. FDA aims to strengthen food safety measures in line
The document discusses reducing transaction costs associated with trade through facilitating compliance with sanitary and phytosanitary (SPS) requirements. It outlines how SPS measures can increase transaction costs for producers and consumers if they are not standardized or scientifically justified. The document recommends ways for countries and firms to analyze SPS requirements, comply with trading partners' regulations to minimize trade losses, and pursue long-term solutions like international standards and agreements.
Chapter 6; eco labelling (oeko tex-100 and eu eco-label)Shaheen Sardar
The document summarizes information about two eco-labeling schemes - Oeko-Tex and the EU Ecolabel. Oeko-Tex is a voluntary certification system that tests textiles for harmful substances. It has four product classes based on a product's contact with skin. The EU Ecolabel aims to encourage environmentally friendly products and has criteria covering the entire life cycle from extraction to disposal. Both labels provide advantages to textile producers including health and environmental protections.
This document summarizes the global regulatory landscape for biosimilars. It begins by defining biosimilars and biological drugs. It then discusses the guidelines established by various regulatory bodies including the EMA, FDA, WHO, and agencies in countries like Japan, Korea, Canada, China, and India. The guidelines generally require demonstrating biosimilarity to the reference product through comparative quality, nonclinical and clinical studies. The document also discusses business opportunities for biosimilars in emerging versus established markets and strategies used by originator companies to combat biosimilar competition. It concludes by noting concerns around interchangeability between biosimilars and reference products.
This document discusses biologics and biosimilars. It defines biologics as biological products made from natural sources like humans, animals or microorganisms that are used to treat or prevent diseases. Biosimilars are highly similar versions of biologics that are approved because they have no clinically meaningful differences. The document outlines key differences between biologics and biosimilars like regulatory pathways and development testing. It also compares biosimilars to generics and discusses important considerations for biosimilar development like immunogenicity, bioequivalence and post-translational modification.
FDA 2013 Clinical Investigator Training Course: Biosimilar Biological ProductsMedicReS
This document provides an overview of biosimilar biological products from a presentation given by Dr. Sue Lim of the FDA. It defines biological products and biosimilars. Biosimilars are developed using a stepwise approach to demonstrate biosimilarity to a reference product through analytical, nonclinical and clinical studies. Clinical study design considerations for biosimilars include using endpoints sensitive to potential differences, assessing products at time points most likely to detect differences, using the same or similar patient populations and doses as the reference product, and evaluating safety including immunogenicity over a duration adequate to detect potential impacts.
Determinations for lead and the eight elements in ASTM F963 as a means for third party testing cost reduction: questions, issues, and comments. CPSC staff presentation followed by panelist presentations
This document discusses biosimilars and their regulation. It begins with a brief history of biotechnology and biopharmaceuticals. It then defines biosimilars as similar but not generic versions of biologic drugs whose patents have expired. The document outlines key differences between biosimilars and generic drugs, including their larger and more complex molecular structures. It also discusses concerns regarding biosimilar efficacy, safety, interchangeability, and pharmacovigilance. Finally, it provides an overview of regulatory frameworks for biosimilars in various regions like the EU, US, India, and WHO guidelines.
This working paper discusses preliminary results from a survey of 15 biopharmaceutical manufacturing sites regarding regulatory economics. The survey collected data on site characteristics, quality approaches, and perceptions of regulatory inspections. Logistic regression found some factors like prior production elsewhere or use of mammalian cell culture were statistically related to reported quality deviations. The full project aims to incorporate FDA inspection data and understand how globalization impacts regulatory compliance in biopharmaceutical manufacturing to help inform FDA policy.
Instrument or Experimental Technique Used In Food Chemical Composition Analysisholem
This document discusses four main analytical instrument techniques used in food chemical composition analysis: gas chromatography (GC), high performance liquid chromatography (HPLC), differential scanning calorimeter (DSC), and ultraviolet-visible spectrophotometer. It provides an overview of each technique, including their aims and uses in food analysis. GC is used to separate and analyze compounds that can be vaporized, HPLC separates mixtures using liquid mobile and stationary phases, DSC measures heat flows during material transitions, and UV-VIS spectrophotometry determines substance identities and concentrations by measuring light absorption.
This document provides an overview of eco-labels in textiles. It discusses the history and rise of eco-labels in the 1970s-1980s to address consumer confusion over environmental claims. It describes different types of eco-labeling schemes including independent labels, national labels, and multinational labels. It then examines specific eco-label programs like the Blue Angel (Germany), EU Eco-label, and Nordic Eco-labeling scheme, outlining their objectives, product categories, features, and chemical restrictions.
February 7, 2017
Many of today’s important medications are biological products made from living organisms, manufactured through biotechnology, derived from natural sources, or produced synthetically. Biosimilars are a type of biological product approved by FDA on the basis of being highly similar to an already approved biological reference product.
This panel of experts discussed the current state of biosimilars in the healthcare ecosystem and what comes next from a technical and legal perspective. Topics included how the next generation of biosimilars could improve patient access to standard-of-care therapies, the concept of “biobetters,” economic and intellectual property considerations, and policy approaches to support existing and future biosimilars.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/looking-forward
Phthalate determinations as a means for third party testing cost reduction: questions, issues, and comments. CPSC staff presentation followed by panelist presentations.
With 35+ years of experience across the food science and packaging spectrum, Dr Claire Sand, owner and founder of Packaging Technology & Research, helps clients achieve
more sustainable packaging,
increase shelf life/prevent food waste,
leverage food packaging innovations,
address food package optimization
and serves the food and packaging industry as
a food packaging expert witness
adjunct professor
columnist for Food Technology and Packaging Digest
Want to know more about how this article affects your business? Reach out to Dr. Sand on LinkedIn - https://www.linkedin.com/in/clairekoelschsand
Want to keep learning from Dr. Sand? View more of her presentations and articles at https://www.packagingtechnologyandresearch.com/insights.html
Dr. Claire Sand | Owner, Packaging Technology & Research, LLC; Adjunct Professor, CalPoly and Michigan State University; Columnist for Food Technology Magazine and Packaging Digest http://www.packagingtechnologyandresearch.com/
The document discusses the importance of packaging for pharmaceutical products. It outlines several key functions of packaging including uniformity, purity, integrity, minimizing side effects, and ensuring stability and a defined shelf life. It also classifies different types of packaging materials like primary, secondary and tertiary packaging. Specific materials that are used include glass, plastics, polyethylene, polypropylene, and others. The role of packaging technology in preventing counterfeiting is also covered through various techniques like ink technology, RFID tags, tamper-evident stickers, and holograms. Packaging can also help promote patient compliance and provide informative labeling.
This document provides an overview of maximizing and extending shelf-life for food and beverage products. It discusses best before and use by dates, the steps for setting shelf-life which include establishing product parameters, checking legislation, identifying microorganisms of concern, conducting shelf-life testing, and ongoing review. Extending shelf-life can offer benefits but safety and quality must not be compromised. Considerable expertise is needed to properly set or extend shelf-life to ensure legal compliance and protection of consumers.
The document discusses pharmaceutical packaging technology. It covers the functions of packaging which include barrier protection, biological protection, physical protection, information communication, identification, security and convenience. It also discusses the different types of pharmaceutical packaging including primary, secondary and tertiary packaging. Primary packaging materials can include glass, plastic, metal while secondary packaging uses materials like boxes, cartons and shrink wraps. The selection of packaging depends on the dosage form and its requirements to provide stability and prevent chemical reactions or degradation from light, heat and moisture. Packaging ensures safe delivery of drugs to patients and provides important labeling information.
If you have any questions or comments, please send them to connect@tracegains.com. We look forward to hearing from you.
Meeting Description:
Food packaging is an important element to the safety of food and its ingredients, as they travel through the supply chain and on to the consumer.
How can you protect yourself, your brand, your customers, and the end consumer from adverse impacts?
What are best practices you should be paying attention to in manufacturing and purchasing of packaging materials and components?
-How can you proactively monitor and manage your suppliers?
-Debra Krug-Reyes of ConAgra will discuss the need for food safety programs at packaging suppliers.
-George Gansner of IFS will then talk about the role and importance of the Global Food Safety Initiative (GFSI) and International Featured Standards.
This webinar will reveal the history of the IFS PACsecure standard, focus on the benefits of certification to the supplier and customer, as well as review the tools available in support of certification which include HACCP implementation workbooks designed specifically for the sector for which it applies (glass, metal, rigid plastic, flexible plastic, and paper – corrugated, paper board, etc.).
About the IFS PACsecure standard:
Since 2003, IFS has built its presence around the world as a leading standard in the food supply chain, and in 2013, IFS PACsecure was added to the family of GFSI benchmarked certifications. This standard for primary and secondary packaging materials was developed to provide packaging converters the opportunity to certify their systems and products with a HACCP-based approach, using risk-based methodology.
Developed jointly by the food and packaging industry in North America with the guidance of the Packaging Consortium, the IFS PACsecure standard is now globally viable and meets GFSI customer requirements.
The document summarizes recent advances in pharmaceutical packaging technology. It discusses the need for advancements in packaging to improve patient compliance and prevent counterfeiting. Some key packaging innovations highlighted include blow-fill-seal technology, tamper evident packaging using induction sealing and heat shrink bands, and compliance packaging that tracks medication usage via wireless connectivity. The role of quality assurance in packaging is also reviewed to ensure safety and accuracy of packaged pharmaceutical products.
validation of packaging issue by rahul sagar, bbau lucknowBrajesh Kumar
The document discusses packaging validation and quality assurance aspects for pharmaceutical products. It includes:
1. An overview of packaging materials, types of packaging, selection criteria and characteristics required for packaging materials.
2. Details of primary, secondary, and tertiary packaging as well as special packaging types like unit-dose and device packaging.
3. Blister and strip packaging are discussed in more detail including the components, manufacturing process, and common materials used.
Quality assurance ensures high quality packaging and compliance with regulations to avoid issues that could harm patients. Validation is important to confirm the packaging process meets requirements.
Purpose of packaging, Properties of packaging materials, factors influencing choice of packaging, advantages and disadvantages of packaging materials, glass, and glass containers, metal and metal containers, plastic and plastic containers, films, foils and laminates, rubber based materials, closures, tamper resistant packaging, testing and quality assurance of packaging materials, different packing machine, and accessories, organization of packaging line, labeling.
Ralph Moyle gave a presentation at the World of Food Safety Conference in Bangkok on the risks of recycled packaging. He discussed several chemical contaminants that can migrate from packaging into food like PAA, SEM, and mineral hydrocarbon oils found in recycled paper and cardboard. Regulations on food packaging were covered for the EU, China, USA, Australia and New Zealand. Moyle recommended that companies understand the origin of their packaging, work with suppliers to ensure certification that packaging meets legal standards, and implement monitoring and auditing programs.
This document summarizes a training workshop on pharmaceutical development with a focus on pediatric formulations. It discusses considerations for pharmaceutical packaging for pediatric medicines, including choosing the most appropriate primary package, regulatory requirements, and packaging development. Specific topics covered include the roles of packaging, barrier properties of packaging, bottles and closures, blister packs, extractables and leachables testing, and packaging design through product launch.
This document discusses standards and regulations for plastics used in food packaging in India. It begins by defining standards and standardization. It then discusses the growth of plastic packaging and the role of standards in ensuring food safety and facilitating domestic and international trade. The rest of the document outlines various Indian standards set by the Bureau of Indian Standards regarding specifications for food contact plastics and packaging, test methods, and standards for specific food products and packaging materials.
Sustainability & Public Health - The Role of Packaging | P2SPack2Sustain, LLC
Pack2Sustain is a technical services firm that works to optimize packaging systems through technology scoping and life-cycle analysis. Packaging impacts sustainability across economic, social, and environmental dimensions. Socially, packaging plays a key role in public health by protecting medical and food supplies from contamination during distribution. While canned foods can be safer, BPA linings may impact health. Packaging also deters product counterfeiting, especially for pharmaceuticals. Environmentally, packaging protects the resources invested in products and reduces waste throughout the supply chain.
The document discusses pharmaceutical packaging validation. It begins with introductions and definitions of packaging and packaging validation. It then discusses selection criteria for packaging materials, characteristics of materials, types of packaging and materials. The document outlines validation protocols and discusses visual inspection, identification testing, dimensional analysis, and microbiological testing during validation. It also describes blister packaging and strip packaging processes.
Validation of packaging operations PharmaDivesh Singla
The document discusses pharmaceutical packaging validation. It begins with introductions and definitions of packaging and packaging validation. It then discusses selection criteria for packaging materials, characteristics of materials, types of packaging and materials. The document outlines validation protocols and discusses visual inspection, identification testing, dimensional analysis, and microbiological testing during validation. It also describes blister packaging and strip packaging processes.
SPLC 2019 Summit: Purchasing for Zero Waste: 3 Case Studies from Higher Educa...SPLCouncil
Slides from Sapna Thottathil, Associate Director of Sustainability, Office of the President, University of California, Office of the President, presented at the Sustainable Purchasing Leadership Council’s 2019 Summit in Portland, OR.
The International Council for Harmonisation (ICH), formerly the International Conference on Harmonisation (ICH) held the inaugural Assembly meetings on 23 October 2015 establishing ICH as an international association, a legal entity under Swiss law.
This step built upon a 25-year track record of successful delivery of harmonised guidelines for global pharmaceutical development as well as their regulation, and a longer standing recognition of the need to harmonise.The guidance stated in the ICH harmonized tripartite guideline entitled “Stability Testing of New Drug Substances and Products” (issued by ICH on October 27, 1993) applies in general to biotechnological/biological products.
Packaging design & innovation in foods and beveragesinewtrition
Do you want to choose the right packaging for your new product?
Do you want to strengthen your existing product as part of your marketing strategy and consider the alternatives to your current packaging?
Creating or selecting a food package is partly art and partly science. Both are significant and go hand in hand. Besides, designers must evaluate the technology push, market pull and socioeconomics carefully for successful packaging design.
To average consumers, food packaging is simply the enclosure of a food product in a plastic pouch, a metal can, or a glass bottle. To scientists or engineers, food packaging is a rather technical subject – it is a coordinated system designed for the efficient delivery of high quality, safe food products throughout the supply chain and the shelf-life. However, for food entrepreneurs, food packaging is all the above and more. The packaging gives you innovative ways to reach your customers. It enables you to communicate with your consumers as a marketing tool. For more information, please contact Raphaelle at info@inewtrition.com
This document discusses key aspects of pharmaceutical packaging design and specifications. It begins by introducing packaging as integral to new product development and quality control. It then covers types of packaging, objectives of packaging, and why standardized designs are important for regulatory compliance and production efficiency. The document outlines important considerations for packaging design like marketing involvement, validation trials, and customer usability. It also discusses component specifications, quality testing standards, and layout of specification documents. Overall, the document provides a comprehensive overview of pharmaceutical packaging design and specifications from conceptualization through regulatory requirements.
This document discusses various aspects of pharmaceutical packaging design and specifications. It begins with short introductions to packaging, objectives of packaging, and types of packaging. It then covers topics like packaging design considerations, component specifications, quality testing standards, and regulatory requirements. The key points are that packaging must protect products, provide information to customers and compliance, and quality control starts at the design stage. Component specifications involve drawings, artwork, material selection, and defining test standards.
Similar to Flexible Packaging Safety White Paper (20)
1. The Current Regulatory and Risk
Landscape for
Flexible Food Packaging
White Paper
Ashland Specialty Ingredients, Adhesives
Dublin, Ohio
ashland.com/safepackaging
+1 877 546 2782
2. Overview
Requirements for food packaging safety are becoming
increasingly stringent. Brand owners and material suppliers
are being pressured to guarantee the safety of their packaging
by non-governmental organizations, grassroots consumer
advocates, and even the media. Brand owners are, in turn,
pressuring the supply chain to conform to negative lists –
chemicals that brand owners have declined to use – despite
those products holding government approvals. Companies
are also asking supply chain vendors to demonstrate safety
through testing and migration studies, as well as by providing
highly detailed formulation disclosures. Some brand owners
and converters have requirements that hold packaging
and ingredient suppliers to the same standards as food
manufacturers, mandating Good Manufacturing Practices
(GMP) or Hazard Analysis Critical Control Point (HACCP)
procedures even though these efforts may not be required by
regulation. Today, simply obtaining a packaging compliance
letter from a raw material supplier, or assuming that the
package construction will prevent chemical migration, is not
enough.
Material suppliers must be cognizant of the potential hazards
their products may bring to the food packaging supply chain.
Suppliers must understand the risk profile of their products
for their customers’ end uses. This can only be done by
knowing the components of the raw material supply chain,
their conditions of use, the types of food to be packaged,
and the migration potential of the packaging components. If
a packaging supplier understands these elements, they can
understand the risk profile of their product and can make a
determination as to whether their product is fit for its intended
use.
Flexible Packaging and its Relationship to Food
Packaging Regulation and Risk
Flexible packaging currently has the highest global growth
rate of all packaging options. Unlike rigid packaging, flexible
packaging typically requires fewer materials that weigh less,
so it can be cost-effectively manufactured and shipped.
Material innovations are yielding more sustainable solutions,
including down-gauging, which leads to lower cost and
greater downstream packaging equipment efficiencies. Energy
costs are significantly lower at each stage of the supply chain
compared to other packaging options.
This rapid growth and innovation in flexible packaging has
given rise to new challenges and potential safety risks born
out of new chemistries and material combinations outpacing
hazard data development and regulation. This is readily
observed with newer technologies that rely on technologies
such as ultraviolet (UV), electron beam (EB), and, more recently,
UV light-emitting diode (LED) radiation-curable materials.
Efforts to decrease weight and cost through film down-
gauging has resulted in thinner barriers to prevent migration.
Brand owners are also trying to meet consumer demands
for added convenience with packaging that is microwavable,
ovenable, or otherwise subject to extreme conditions. These
demands can also increase chemical migration.
With these trends and regulations, and hazard data unable to
keep pace, the burden to provide effective, safe, and compliant
packaging will continue to fall on the shoulders of the flexible
packaging supply chain.
Regulations for Flexible Food Packaging
In the United States, the Food and Drug Administration
(FDA) regulates food packaging, and all materials must have
premarket clearance before they can be used. Premarket
clearance typically means the materials are listed in Title 21 of
the Code of Federal Regulations (e.g., 21 CFR 175.105, 175.300,
177.1630). In addition to using 21 CFR to determine pre-market
clearance, the FDA allows the use of materials which are 1)
Generally Recognized as Safe (GRAS) as demonstrated by
published toxicological data, 2) materials for which the FDA has
granted prior sanction (pre-1958), and 3) materials which are
not expected to become a component of the diet as described
in 21 CFR 170.39 (Threshold of Regulation).
Additionally, a company may ask the FDA to review new
packaging materials under the Food Contact Notification (FCN)
Program. The FCN program provides an excellent opportunity
for flexible packaging suppliers to demonstrate safety via FDA
review of the product and its intended use. Unfortunately,
many new technologies, such UV, EB, and LED, do not have
premarket clearance. FCN submissions for these types of
technologies remain sparse. If the packaging components do
not meet the premarket requirement(s) listed above and later
migrate into the food, the food is automatically considered
adulterated by FDA.
In the European Union, the Framework Regulation (1935/2004)
regulates materials and articles that come into contact with
food. Article 3 of the Framework Regulation requires that
materials and articles must be manufactured in accordance
with GMP and must not transfer constituents to food that can
endanger human health, change the composition of the food,
or deteriorate the organoleptic (taste/smell) properties of the
food. The European Food Safety Authority (EFSA) reviews new
materials for use in food packaging and issues opinions and
restrictions for food contact materials. Beyond the Framework
3. Regulation, the EU has developed harmonized measures to
address specific food contact materials. The most notable
is the Plastics Implementing Measure (PIM, 10/2011), which
regulates plastics such as the polymeric films used in flexible
packaging. However, the EU has not issued harmonized
measures for materials such as inks, coatings, and adhesives,
making it difficult for flexible packaging suppliers to determine
compliance and safety. Flexible packaging suppliers must rely
on Article 3 of the Framework Regulation. They must ensure
the packaging materials are safe for intended use and do not
affect the odor, taste or composition of the food.
Determining Fitness for Use in the Absence of
Specific Regulations
How can suppliers, brand owners and converters determine if a
product is fit for use without FDA premarket clearance or listing
under an EU-harmonized regulation?
Many technologies used in flexible food packaging are
separated from the food by a polymeric film. In general,
the flexible packaging industry has assumed that for lower-
temperature applications (anything <49 °C), any barrier will
prevent chemical migration into food. This is commonly
referred to in the industry as “indirect contact.” This idea
assumes that the polymeric film is a functional barrier.
Polyethylene terephthalate (PET) film >1 mm would meet
this criterion. However, most other polymeric films do not.
Films have very different barrier properties depending on
their thickness, the environmental conditions (particularly
temperature), and the food contained within.
Probably the most frequently used barrier film is LLDPE, but
it is a poor barrier depending on the conditions. The barrier
properties of some common polymeric films are listed below,
from lowest to highest.
Linear low-density polyethylene (LLDPE)
High-density polyethylene (HDPE)
Polypropylene (PP)
Polyethylene terephthalate (PET)
Some materials have been well studied for migration and have
low toxicity profiles, making them of little concern. There are,
however, a multitude of chemicals used in flexible packaging
that have no migration data or are known to have high
toxicity profiles. For these chemicals, a general assumption
that any polymeric film is automatically a functional barrier
under all conditions could lead to unintended contamination
– potentially resulting in product recalls, unwanted media
scrutiny, and/or government intervention.
Companies could reduce the risk of exposure to such
consequences if they reviewed their products using a fit for
use approach, particularly for materials that lack premarket
clearance or regulatory listing.
Frequently, flexible packaging manufacturers and suppliers
rely on raw material compliance letters as guarantees of
safety. However, certain components may not appear on
the Certificate of Analysis. Further, by-products caused by
incidental exposure or chemical reactions, such as oxidation,
are also not accounted for on CA documents. Efforts should
be made to know the materials used in manufacturing, either
through extensive communication with the raw material
supplier or analysis of the raw material.
Determinaton of Fitness for Use
A fit for use determination requires a complete understanding
of: 1) the formulation of raw materials, including base
chemistries, contaminants, and by-products; 2) the end-use
profile of the packaged product; 3) the migration profile of the
product based on its end use; and 4) a risk assessment of the
migrants.
To design and execute appropriate migration studies or
diffusion calculations, suppliers must understand the end use
of their products, including:
• packaging structures (films, primers, inks, coatings,
adhesives, etc.)
• range of temperatures to which the product materials will
be exposed
• types of food that will go into that package
• anticipated shelf life of the packaged food
Perhaps most critical is a complete understanding of the
film that will be in contact with the food. The density,
gauge, molecular weight distribution, comonomer type,
long chain branching level and distribution, and blown-film
process represent the key variables that affect the crystalline
morphology. This morphology is what constitutes the barrier
qualities of any given package.
In addition, how the material is stored can affect migration. For
example, during manufacture, package material coming off
a laminator is stored in rolls. This puts the non-food-contact
side (outside) of the packaging in direct contact with the
food-contact side (inside) of the packaging. This may create
a condition to allow incidental chemical migration (off-set) to
occur during storage.
As temperature and time increase, so does migration. FDA and
4. EFSA have provided guidance for temperature and time condition migration testing. These guidelines also address extended shelf
life, so materials don’t need to be tested for the full shelf life period.
For example, FDA recommends testing at 40 °C for 10 days to mimic 6-12 months shelf life for food stored at room temperature.
FDA and EFSA time and temperature guidance are listed in Tables 1 and 2a/2b, respectively. Please note that this is not the
complete guidance. Consult FDA1 and PIM2 (10/2011) for additional details.
Table 1. FDA Time and Temperature Guidance[1]
FDA Condition of Use
A. High temperature, heat sterilized or retorted 2 hours at 121 °C followed by 10 days at 40 °C
B. Boiling water sterilized 2 hours at 100 °C followed by 10 days at 40 °C
C. Hot filled or pasteurized above 66 °C 2 hours at 66 °C followed by 10 days at 40 °C
D. Hot filled or pasteurized below 66 °C 30 minutes at 66 °C followed by 10 days at 40 °C
E. Room temperature filled and stored 10 days at 40 °C
F. Refrigerated storage 10 days at 20 °C
G. Frozen storage 5 days at 20 °C
H. Frozen or refrigerated storage; ready-prepared foods intended to be
reheated in container at time of use
2 hours at 100 °C followed by time temperature of storage
I. Irradiation (ionizing radiation) Consult with FDA
J. Cooking at temperatures exceeding 121 °C Consult with FDA
Table 2a. European Union Time and Temperature Guidance from Plastics Implementing Measure (10/2011) [2]
Contact time in worst foreseeable use Test Time
t ≤ 5 min 5 min
5 min < t ≤ 0,5 hour 0,5 hour
0,5 hours < t ≤ 1 hour 1 hour
1 hour < t ≤ 2 hours 2 hours
2 hours < t ≤ 6 hours 6 hours
6 hours < t ≤ 24 hours 24 hours
1 day < t ≤ 3 days 3 days
3 days < t ≤ 30 days 10 days
Above 30 days See specific conditions
Table 2b. European Union Time and Temperature Guidance from Plastics Implementing Measure (10/2011) [2]
Conditions of contact in worst foreseeable use Test conditions
Contact temperature Test temperature
T ≤ 5 °C 5 °C
5 °C < T ≤ 20 °C 20 °C
20 °C < T ≤ 40 °C 40 °C
40 °C < T ≤ 70 °C 70 °C
70 °C < T ≤ 100 °C 100 °C or reflux temperature
100 °C < T ≤ 121 °C 121 °C
121 °C < T ≤ 130 °C 130 °C
130 °C < T ≤ 150 °C 150 °C
150 °C < T ≤ 175 °C 175 °C
T > 175 °C Adjust the temperature to the real temperature at
the interface with the food (*)
* This temperature should be used only for food
stimulants D2 and E. For applications heated under
pressure, migration testing under pressure at the
relevant temperature may be performed. For food
stimulants A, B, C or D1, the test may be replaced
by a test at 100 °C or at reflux temperature for
duration of four times the time selected according
to the conditions in Table 2A.
5. The type of food inside the package also affects the migration
of chemical substances based on the chemistry of the food
and migrants. Fatty foods and aqueous foods tend to pull
lipophilic chemicals and hydrophilic chemicals from the
package, respectively. Migration testing in specific foods is not
required as FDA and EFSA have provided lists of solvents that
act as food simulants. It is absolutely necessary to test products
in the proper simulant representing the food that is intended
to be packaged. The recommended food simulants for FDA
and PIM (10/2011) are listed in Tables 3 and 4. The FDA also
recognizes 95% ethanol as an effective fatty food simulant
in its Chemistry Guidance, and 3% acetic acid can be used in
lieu of 10% ethanol when food acidity is expected to lead to
significantly higher levels of migration or there is a chemical
interaction between the chemical migrant and ethanol.[1]
In
addition, an example of food types is provided in Table 5.
Table 3. FDA Food Simulants[1]
Food Type Recommended Simulant
Aqueous & Acidic Foods 10% Ethanol
Low- and High-Alcoholic Foods 10 or 50% Ethanol
Fatty Foods Food oil (e.g., corn oil), HB307,
Miglyol 812, or others
Table 4. Plastic Implementing Measure (10/2011)
Simulants[2]
Food Simulant Abbreviation
Ethanol 10% (v/v) Food simulant A
Acetic acid 3% (v/v) Food simulant B
Ethanol 20% (v/v) Food simulant C
Ethanol 50% (v/v) Food simulant D1
Vegetable oil Food simulant D2
Poly(2,6-diphenyl-p-phenylene
oxide), particle size 60-80 mesh,
pore size 200 nm
Food simulant E
Table 5. Food Type Examples [3]
Food Type Example
Aqueous Fruits, vegetables, juices, mustard,
ketchup, salad, milk, bread
Alcoholic Beer, ale, wine, distilled spirits
Fatty Cheese, butter, meats, seafood, ice
cream, doughnuts, cookies, potato
chips, nuts
Dry Uncooked pasta, cereals, rice cakes,
coffee
Effects of Food Simulant, Temperature, and
Time On Material Migration
The following tables demonstrate the effect of food simulant,
time, and temperature on aromatic isocyanate migration from
a laminating adhesive through LLDPE. Aromatic isocyanates
were investigated because of their common use in adhesives
and their ability to quickly form aromatic amines in the
presence of water. Aromatic amines are carcinogens and their
potential to migrate need to be carefully monitored. The data
presented is a typical aromatic isocyanate-based laminated
adhesive currently in the market.
Table 6. Effect of Food Simulant on Migration
Adhesive
Cure Time
3% Acetic Acid
Simulant Migration
(ppb)*
95% Ethanol
Simulant Migration
(ppb)**
2 days 6.1 174.7
3 days 2.9 73.0
7 days 3.7 3.9
Sealant film – 1.0 mil LLDPE; Test condition – 2 hours @ 70 °C
* Measurement of aromatic amine (UV/Vis)
** Measurement of the diethylurethane of methylene diphenyl diisocyanate (HPLC/UV)
As Table 6 exhibits, migration into a fatty food simulant (95%
ethanol) is greatly enhanced when compared to an aqueous
food simulant (3% acetic acid).
Table 7. Effect of Time and Temperature on Migration
Adhesive Cure
Time
Room Temp.
Migration (a)
(ppb)*
FDA Condition
of Use H
Migration (b)
(ppb)*
Hot Fill w/
Extended
Shelf Life
Migration (c)
(ppb)*
2 days 7.7 95 345
4 days 0.9 9.3 24.7
7 days 0.7 1.5 2.7
Sealant film – 3.0 mil LLDPE; simulant – 95% ethanol
*Measurement of diethylurethane of 4, 4’-methylene diphenyl diisocyanate (HPLC/UV)
Test conditions: (a) 10 days @ 40 °C, (b) 2 hrs. @ 100 °C, (c) 2 hrs. @ 100 °C + 96 hrs. @ 40 °C
Table 7 shows the effect of temperature on aromatic
isocyanate migration – as temperature increases so does
migration. The table also demonstrates that as shelf life
increases, migration is significantly enhanced (i.e., 2 hours at
100 °C followed by 4 days at 40 °C compared to just 2 hours at
100 °C).
Tables 6 and 7 clearly demonstrate the effect that food
simulant, temperature, and time can have on chemical
migration. When testing migration for food packaging, flexible
6. packaging manufacturers and suppliers must perform the
migration study that matches the customer’s end use. If
migration testing does not mimic customer end use, then
there is potential that exposure and consumer risk will be
underestimated.
Risk Assessment of the Food Package
The flexible packaging manufacturer and supplier must
determine which chemicals are likely to migrate, determine
the hazards of the migrants, and then establish an appropriate
detection limit based on the hazards and potential exposure.
In Europe, there are detection limits in the PIM for some
chemical migrants. These are known as Specific Migration
Limits (SML). FDA does not publish SML, so flexible packaging
manufacturers must rely on risk-based approaches to
determine a suitable detection limit (i.e., hazard of the material
is evaluated, a safe dietary level is determined, and from the
dietary level, the detection limit can be established).
After the migration studies or diffusion calculations have
been performed, the product needs to be risk assessed for its
intended use. In essence, this is simply evaluating the migration
values against the detection limits. If the migration results are
below the detection limit for the appropriate conditions of use,
then a conclusion can be made that the packaging product is
safe for use.
Summary
A determination of fitness for use requires an understanding
of the raw material supply, the conditions of use, the types of
food to be packaged, and the hazards of the chemicals that
are likely to migrate, as well as migration testing or calculations
using SML or risk-based detection limits to determine if the
level of migration is below levels that could be of concern. A
step-by-step approach may look something like this:
1. Review product formulation for compliance with
applicable regulation and any toxicological issues.
• This allows the supplier to know if a material will need to
be registered in a particular geography or if a particular
migrant will be problematic, i.e., banned for food
applications.
2. Understand the package structure, the food types to be
packaged, and the conditions the package is designed to
encounter.
• This will determine the appropriate conditions for
migration testing.
3. Determine all migrants (including oligomers) and
acceptable detection limits based on validated and
conservative toxicological data and exposure potential or
suitable SML.
4. Perform migration testing, migration calculations, or
diffusion calculations and compare values to detection
limit or applicable SML.
If flexible packaging manufacturers and suppliers follow these
steps, then they should be able to determine if their product is
safe and fit for use.
References
[1] Guidance for Industry: Preparation of Premarket
Submissions for Food Contact Substances: Chemistry
Recommendations document prepared by the United
States Food and Drug Administration. Retrieved from
http://www.fda.gov/Food/GuidanceRegulation/
GuidanceDocumentsRegulatoryInformation/
IngredientsAdditivesGRASPackaging/ucm081818.htm.
[2] Commission Regulation (EU) No 10/2011 of 14 January
2011 on plastic materials and articles intended to come
into contact with food (Text with EEA relevance). Retrieved
from http://eur-lex.europa.eu/LexUriServ/LexUriServ.
do?uri=OJ:L:2011:012:0001:0089:EN:PDF
[3] Technical Advisor’s Report to the Food, Drug, and
Cosmetic Packaging Materials Committee “FDA and EU
Food Types.” Prepared by Dr. Lester Borodinsky, Keller and
Heckman LLP, for the June 20-23, 2005 meeting of The
Society of the Plastics Industry, Inc.’s (SPI) Food, Drug, and
Cosmetic Packaging Materials Committee, Pentagon City,
Virginia, Ritz-Carlton. http://www.plasticsindustry.org/files/
about/fdcpmc/techpdfs/FDA%20and%20EU%20Food%20
Types,%20June%202005.pdf